The possible mechanisms of the HPS/EPO effect were suggested to be related to the PUFA present in both oils, and their metabolites affected inflammatory functions and cytokines production during the 6 months because ω3-PUFAs can suppress IFN-γ production in MS patients [87]. The gene discussed is EPO; the disease is myeloid sarcoma.